Suppr超能文献

胎儿垂体切除或肾切除后血浆中的生长调节素样活性以及绵羊实验性子宫内生长迟缓中的该活性。

Somatomedin-like activity in plasma after foetal hypophysectomy or nephrectomy and in experimental intra-uterine growth retardation in sheep.

作者信息

Falconer J, Forbes J M, Hart I C, Robinson J S, Thorburn G D

出版信息

J Endocrinol. 1979 Oct;83(1):119-27. doi: 10.1677/joe.0.0830119.

Abstract

Plasma samples from pregnant ewes and their foetuses during the last quarter of gestation were assayed for somatomedin-like activity (SLA) using the procine costal cartilage assay. In maternal plasma, the mean potency (compared with pooled serum from six sheep) was 0.84 +/- 0.05 (S.E.M.) units/ml (n = 15). Somatomedin-like activity in the plasma of five control foetuses (0.91 +/- 0.1 units/ml) was similar to the maternal levels and did not change with gestational age. After foetal hypophysectomy the SLA in foetal plasma (0.37 +/- 0.05 units/ml, n = 4) was significantly less than in control animals. In two nephrectomized foetuses, the mean SLA in plasma (0.08 and 0.51 units/ml respectively) was less than in control animals. Retardation of intra-uterine foetal growth was induced by removal of endometrial caruncles before pregnancy in four sheep. The SLA in plasma from these foetuses was 0.38 +/- 0.05 units/ml (P less than 0.01 v. control animals). The results suggest that SLA in the foetus may be important in the regulation of foetal growth, but they also indicate that factors other than growth hormone may be important in the control of SLA in foetal plasma.

摘要

在妊娠最后一个季度,采集怀孕母羊及其胎儿的血浆样本,使用猪肋软骨试验测定其中类生长调节素活性(SLA)。在母体血浆中,平均效价(与六只绵羊的混合血清相比)为0.84±0.05(标准误)单位/毫升(n = 15)。五只对照胎儿血浆中的类生长调节素活性(0.91±0.1单位/毫升)与母体水平相似,且不随胎龄变化。胎儿垂体切除术后,胎儿血浆中的SLA(0.37±0.05单位/毫升,n = 4)显著低于对照动物。在两只肾切除的胎儿中,血浆中的平均SLA(分别为0.08和0.51单位/毫升)低于对照动物。在四只绵羊怀孕前切除子宫内膜肉阜,诱导宫内胎儿生长迟缓。这些胎儿血浆中的SLA为0.38±0.05单位/毫升(与对照动物相比,P<0.01)。结果表明,胎儿体内的SLA可能在胎儿生长调节中起重要作用,但也表明,除生长激素外的其他因素可能在胎儿血浆中SLA的控制中起重要作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验